Reappraisal of carcinoma in situ residue at the bile duct margin: a single-center review of 681 patients with perihilar cholangiocarcinoma
HPB · 2025
DOI: 10.1016/j.hpb.2024.12.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2025. Verfasst von Ryusei Yamamoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Pathology and Clini…. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Klatskin Tumor, Margins of Excision, Carcinoma in Situ. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND: A histologically involved surgical margin (R1) is often observed after resection for cholangiocarcinoma. Compared with a negative margin (R0), R1 with invasive carcinoma (R1inv) markedly worsens survival, whereas the prognostic effect of R1 with carcinoma in situ (R1cis) remains controversial. METHODS: Patients who underwent resection for perihilar cholangiocarcinoma between 2002 and 2019 were retrospectively reviewed. According to the pathological assessment, the duct margin was classified as R0, R1cis, or R1inv; radial margin positivity was treated as R1inv. Recurrence and survival were compared. RESULTS: Among the 681 patients, 457 had R0, 69 had R1cis, and 155 had R1inv. The overall five-year recurrence rate was 82.8 % with R1inv, 67.8 % with R1cis, and 47.6 % with R0 (P < 0.001); the local recurrence rate also significantly differed among these groups (P < 0.001). The five-year survival rate was significantly worse with R1cis than with R0 (37.3 % vs. 56.7 %, P < 0.001) and better than that with R1inv (20.9 %, P = 0.007). Multivariate analysis revealed that R1cis was an independent predictor of survival (hazard ratio, 1.65; P < 0.001). CONCLUSION: Compared with R0, R1cis significantly deteriorated overall survival in the whole resection subset of patients with perihilar cholangiocarcinoma. However, the prognostic impact of R1cis was milder than that of R1inv.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Pathology and Clinical Laboratories, Nagoya University Graduate School of Medicine, Nagoy…
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Pathology and Clinical Laboratories, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: ebata.tomoki.n1@f.mail.nagoya-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yamamoto, R., Onoe, S., Mizuno, T., Watanabe, N., Kawakatsu, S., Sunagawa, M., Yamaguchi, J., Ogura, A., Baba, T., Igami, T., Yamada, M., Shimoyama, Y., & Ebata, T. (2025). Reappraisal of carcinoma in situ residue at the bile duct margin: a single-center review of 681 patients with perihilar cholangiocarcinoma. HPB. https://doi.org/10.1016/j.hpb.2024.12.005
Vancouver
Yamamoto R, Onoe S, Mizuno T, Watanabe N, Kawakatsu S, Sunagawa M, et al. Reappraisal of carcinoma in situ residue at the bile duct margin: a single-center review of 681 patients with perihilar cholangiocarcinoma. HPB. 2025. doi:10.1016/j.hpb.2024.12.005
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Ryusei and Onoe, Shunsuke and Mizuno, Takashi and Watanabe, Nobuyuki and Kawakatsu, Shoji and Sunagawa, Masaki and Yamaguchi, Junpei and Ogura, Atsushi and Baba, Taisuke and Igami, Tsuyoshi and Yamada, Mihoko and Shimoyama, Yoshie and Ebata, Tomoki},
title = {Reappraisal of carcinoma in situ residue at the bile duct margin: a single-center review of 681 patients with perihilar cholangiocarcinoma},
journal = {HPB},
year = {2025},
doi = {10.1016/j.hpb.2024.12.005}
}
EUVIMED